Bone Growth Stimulator Market- Global Industry Size, Share, Trends, Analysis and Forecast 2020 – 2023

 Bone growth stimulators are devices which promote bone health in situations of critical fractures. These devices can use electric current to expedite the healing process. The global bone growth stimulator market report by Market Research Future (MRFR) comprises analysis of latest trends in bone repair, patents of latest devices, and market dynamics for the period of 2018 to 2023 (forecast period). The impact of the COVID-19 pandemic and its effects are also included in the report.

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/6962

Bone Growth Stimulator Market Scope

Global bone growth stimulator market is expected to grow significantly over the forecast period. The market held a market value of USD 1,213 million in 2017 and is projected to grow at a CAGR of 5.86% over the forecast period. Preference of electric bone stimulation in lieu of surgeries can drive the market growth. According to clinical trials conducted by the Cedars-Sinai Hospital, electric bone growth stimulators can expedite the healing process in ankle fractures. Success of these trials can pave the path for the global bone growth stimulator market.

Bone Growth Stimulator Market Segmentation

The global bone growth stimulator market has been segmented by product, application, and end user.

By product, the market has been segmented into platelet-rich plasma, bone growth stimulation devices, bone morphogenetic proteins, and others. The bone growth stimulation devices segment is further segmented into ultrasonic bone growth stimulators, external bone growth stimulators, and implanted bone growth stimulators. Among the product segment, bone growth stimulation devices are expected to account for the largest share in the global bone growth stimulator market in 2017. This is majorly attributed to the wider acceptance of the devices and better patient compliance.

On the basis of application, the market has been segmented into oral and maxillofacial surgeries, spinal fusion surgeries, delayed union & non-union bone fractures, and others. The spinal fusion surgeries segment is expected to lead in the global bone growth stimulator market in 2017.

On the basis of end users, the market has been segmented into academic and research institutes, hospitals & clinics, home care and others. The hospitals & clinics segment is expected to account for the largest share in the global bone growth stimulator market in 2017. However, growth of home care services in the developed and developing countries has been estimated to drive the segment growth during the forecast period.

Bone Growth Stimulator Market Regional Analysis

Based on the regions, the bone growth stimulator market is segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).

Geographically, the Americas is anticipated to dominate the global bone growth stimulator market owing to the rising prevalence of the orthopedic and spinal ailments such as bone fractures and spinal damage. Development of better therapeutic approaches and advanced treatments has positively affected the regional market growth. Moreover, increasing numbers of spinal fusion procedures, patient preference for orthopedic fixation procedures, high awareness among the population, and high disposable income levels are some of the factors driving the bone growth stimulator market growth.

Europe is expected to hold the second largest market share in the global bone growth stimulator market. The market growth is majorly attributed to the increasing government support for the device manufacturers. Establishment of manufacturing units of medical device companies in this region has brought traction to bone growth stimulators.

Similarly, APAC has observed a rapid growth in the bone growth stimulator market owing to continuous developments in the healthcare sector. Moreover, increase in government funding for healthcare, a rise in R&D expenditure, and growing number of medical device companies in the region is predicted to be highly lucrative for the market in the region.

Lastly, the MEA region is anticipated to show a modest growth rate in the bone growth stimulator market during the forecast period.

Bone Growth Stimulator Market Competition

Depuy Synthes, Harvest Technologies, Orthofix International N.V., Stryker Corporation, Isto Biologics, DJO Finance LLC, Zimmer Biomet Holdings, Inc., Arthrex, Inc., Bioventus LLC, and Medtronic PLC are key players of the global bone growth stimulator market.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/bone-growth-stimulator-market-6962

 

Healthcare Asset Management Market Global Analysis & Forecast to 2023 Research Report

 Healthcare Asset Management Market Overview

Healthcare asset management uses technologies such as Radiofrequency Identification (RFID) and plays a significant role in making efficient use of medical equipment, maintaining inventories, and minimizing human error. The hospital asset management system helps monitor and secure hospital facilities and uses automated software systems to track the environment on the hospital campus.

As per Market Research Future (MRFR) analysis, the healthcare asset management market is projected to grow at a CAGR of 18.2% from 2018 to 2023 (forecast period). The report on healthcare asset management is a comprehensive analysis and overview of drivers, restraints, opportunities, market trends, market size, forecasts, and developments in the healthcare asset management market. 

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/6335

Healthcare Asset Management Market Dynamics

The increasing concern for patient safety, the need to make available resources more effective, and the adoption of advanced technology in the healthcare sector is expected to drive the healthcare asset management market growth. In addition, increasing investment in R&D and strategies adopted by major players such as the production of new products are contributing to market growth. For example, in August 2018, the latest version of Enterprise Asset Management (EAM) software was announced by Infor Inc., which is a major player in the healthcare asset management market.

Increasing concerns about patient safety, system accuracy problems, high deployment costs for healthcare asset management devices, and poor implementation due to organizational and infrastructure issues can impede market growth during the assessment period.

Healthcare Asset Management Market Key Players

Some of the key players in the healthcare asset management market are 

• cenTrak
• Airista Flow
• GE Healthcare
• IBM Corporation
• Infor Inc.
• Tyco Security Products.
• Intelligent InSites
• Motorola Solutions Inc.
• Radianse
• JADAK (a Novanta Company)
• Siemens Healthineers
• Sonitor Technologies
• Stanley Black & Decker Inc.
• Ekahau Inc.

Healthcare Asset Management Market Segmentation

The healthcare asset management market has been segmented on the basis of product, application, end-user, and region.

Based on the product, the market has been categorized as Real-Time Location Systems (RTLS), Radio Frequency Identification (RFID) devices and Ultrasound & Infrared Tags. The real-time location systems (RTLS) section was further divided into hardware, software, and services. The hardware section was further divided into tags/badges, and readers/interrogators.

Radio frequency identification (RFID) systems have been categorized as hardware, software, and services. The hardware section was divided into tags, readers/interrogators, and accessories. Sub-segment tags have been segmented into passive tags, and active tags. The passive tag section was slit into high-frequency (HF) tags, ultra-high-frequency (UHF) tags, and low-frequency (LF) tags. In addition, the application category has been sub-segmented in hospital asset management and pharmaceutical asset management. The hospital asset management section covers equipment monitoring and management, patient management, temperature and humidity monitoring, personnel management and prevention of diseases, and compliance with hand hygiene. The section of pharmaceutical asset management covers anti-counterfeiting drugs and supply chain management.

Based on end-user, the market has been segmented into Hospital/Clinic, Laboratories, Pharmaceutical companies, and Biotechnology.

Healthcare Asset Management Market Regional Analysis

Based on the region, the healthcare asset management market has been segmented into the Americas, Europe, the Asia Pacific, and the Middle East & Africa.

The Americas are expected to dominate the healthcare asset management market due to the introduction of technologically advanced technologies, rising demand for innovative technology to combat counterfeit drugs and the existence of a well-established healthcare system, and the presence of a large network of health service providers. According to the American Hospital Association, there were 5,534 registered hospitals in the US in 2016, about 2,000 hospitals were in rural areas and more than 3,000 hospitals were located in urban areas.

The second-largest market for controlling healthcare assets is projected to be the European market. Business growth in this area can be attributed to government funding and support for the healthcare sector, combined with increased research and development. In addition, growing cases of product counterfeiting are responsible for increasing demand for healthcare asset management services and are therefore contributing to the growth of the market in the region. According to the European Intellectual Property Office, counterfeit drugs are a major concern in the healthcare sector. Revenue of USD 11,5 billion is lost annually as a result of counterfeit drugs and 10% of all globally supplied medicines are forged.

The Asia Pacific is projected to be the fastest-growing healthcare asset management market in the forecast period due to rising demand for easy-to-use asset management tools, rising digitalization in the region, and investment in healthcare and development by market players in the region.

The market in the Middle East and Africa is projected to account for the lowest share of the healthcare asset management market due to the underdeveloped healthcare system, inadequate medical services, and lack of professional expertise. 

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/healthcare-asset-management-market-6335

About Market Research Future:

Market Research Future® has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Our Research Analysts are eager to share their knowledge and assist you in refining market research parameters, choosing right market studies, and evaluating both the market scope and the research methodologies of varied segments.

We bridge the gap between our clients and their clients by identifying and decoding just the target group, while generating leads with the highest accuracy.

Contact Us:

Market Research Future (MRFR)

528, Amanora Chamber

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

 

Skin Graft Market Scenario, Leading Players, Segments Analysis and Growth by Forecast to 2023

 

Market Highlights

The skin graft market share is chiefly driven by rise in cases of accidents, burns, surgeries requiring removal of skin, skin loss due to infection such as necrotizing fasciitis or purpura fulminans and cancer etc. The rise in the number of plastic surgeries due to the growing influence of the fashion and media industry coupled with the development of tourism sector has led to the growth of the market. The global skin graft market represents a bipolar outlook with huge difference in the rural and metropolitan regions. The developed metropolitan regions especially with tourism and fashion industry sectors such as Bangkok, Las Vegas, and Los Angeles etc. have skin graft surgeries disproportionate to their population and needs.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1674

The skin graft market is led by the product development strategy which is being witnessed in the equipment section and most prominently the dermatome. Dermatome is a surgical instrument used to create thin slice the skin in skin grafting. Latest technological developments have led to the development of advanced dermatomes such as air dermatome which is more efficient and allows for greater control and accuracy in slicing skin of uniform thickness. As the use of dermatomes is dependent on the skill of the surgeons, scarcity of skilled surgeons is acting as a constraint on the global skin graft market.

Global Skin graft Market Players:

Skin graft Market Companies profiled in the report are Organogenesis, Inc., Specmed Medical, Stratatech Corp, Tissue Regenix Group PLC, Avita Medical, Convatec Inc, Medrotonic, Coloplast, B.Braun Melsungen, zimmerbiomet, Stratatech Corporation, Zimmer Biomet and others.

Test the market data and market information presented through more than 50 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Global Skin graft Market” Research Report – Forecast to 2023.

Segmentation:
The global skin graft market is segmented on the basis of graft type, graft thickness and applications. Based on graft type, the market has been segmented as autologous, isogeneic, allogeneic, xenogeneic and prosthetic. Based on the graft thickness, the market has been segmented as split-thickness, full-thickness and composite graft. Based on the applications, the market has been segmented as extensive wound, burns, extensive skin loss due to infection, skin cancers and others. Based on the equipment, the market has been segmented as dermatome (knives dermatomes, drum dermatomes, electric dermatomes, air dermatomes), general surgical instruments, consumables and others. Based on the end users, the market has been segmented as hospitals and clinics, academic and research and others.

FOR MORE DETAILS – @  https://www.marketresearchfuture.com/reports/skin-graft-market-1674 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 

Skin Tightening Market Expects An Extensive Growth In Roi Till 2025

 Market Highlights

The Global Skin Tightening Market is forecasted to be valued at USD 6,340.99 Million by 2025 with the CAGR of 6.2% during the forecast period of 2019–2025.

According to International Society of Aesthetic Plastic Surgery (ISAPS), in 2016, estimated the total procedure for skin tightening performed worldwide are 511,481 out of which Japan held the highest number of procedures followed by the US.  The factors that propel the growth of the market are growing geriatric population, increasing advancement in medical technology and the emerging medical aesthetic market.

However, the radiation emitted from skin tightening equipment involve high health-related risk and the stringent government regulations for aesthetic in healthcare is hampering the growth of the skin tightening market.  

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8245 

In the current scenario, several players are dominating the global skin tightening market. The market leaders in skin tightening treatment are involved in merger and acquisition, product development and innovation to increase the foothold in the skin tightening market. For instance, in January 2017, Lynton Lasers launched a stand-alone platform, LUMINA laser & IPL platform, which can perform 24 different aesthetic concern including skin tightening.

Regional Analysis

The global skin tightening market, by region, is segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The skin tightening market in the Americas is estimated to hold the largest market share. In 2016, according to ISAPS, the total number of skin tightening procedure performed are 75,834. The European skin tightening market has been sub-divided into Western Europe and Eastern Europe. Germany is expected to hold the largest market share in the European region followed by Italy.  

The skin tightening market in Asia-Pacific region is expected to be the fastest-growing market, due to increasing research and development funding by the developing countries like China and India for the development of the healthcare sector. The skin tightening market in the Middle East & Africa region has less economic developments and extremely low-income, therefore anticipated to have the least market share but is expected to grow with better opportunities in the coming years.

Segmental Analysis

The global skin tightening market has been segmented based on type, portability, application, end user, and region.

The market, based on type, has been divided into radiofrequency skin tightening, laser skin tightening, ultrasound skin tightening, and others. The radiofrequency skin tightening segment is anticipated to hold the largest share in the market due to the wider preferability and long-lasting results.

The market, based on portability, has been segregated into portable and stand-alone. The stand-alone market is expected to hold the largest share in the market, owing to its increasing application in the medical devices industry.

The market, by application, has been categorized as reduce wrinkles, face lifting, anti-aging, and others. The anti-aging segment is expected to lead the market owing to the increasing focus and concern toward having a youthful appearance.

The market, by end user, has been classified as hospitals & clinics, specialty center, and others. The specialty center segment is anticipated to hold a major share in the market due to the professional skin tightening treatments provided in these establishments.

Key Players

Some of the key players in the global skin tightening market are  ALLERGAN (US), Solta Medical (US), Venus Concept (Canada), SmarterSkin Dermatology (US), INMODE (US), Fotona d.o.o. (Slovenia), BTL (US), Lynton Lasers (UK), EINS MED Co., Ltd (South Korea), ENDYMED MEDICAL (US), and Alma Lasers (Israel). 

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/skin-tightening-market-8245 

Global Durable Medical Equipment Market Solid Segment Analyzed By Latest Trends, Growth Rate And 2025 Insight

 Market Scenario

The global durable medical equipmentmarket is expected to grow significantly over the forecast period. It is anticipated that the market held a market value of USD 1,08,553.8 million in 2018 and is projected to grow at 6% CAGR over the forecast period.

Medical equipment can be classified into two types disposable medical equipment and durable medical equipment. Durable medical equipment is reusable and can be used for the long run. The medical devices such as insulin pump, ostomy bags, and hospital furniture are considered under durable medical equipment and are used for years.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2676  

The growing geriatric patient population, rising demand for medical equipment, and growing technological innovation in the medical devices industry are boosting the market growth. Additionally, the medical coverage provided for medical equipment drives market growth. The different private insurance companies provide insurance coverage for medical equipment drives market growth.

However, the high maintenance and equipment cost, stringent government regulation, and lack of skilled professionals to handle this equipment can hamper the market growth over the forecast period. 

Segmentation

The global durable medical equipment market has been segmented into device type and end user.

The global market, based on device type, has been segmented into personal mobility devices, medical furniture, monitoring and therapeutic devices, and bathroom safety devices. The personal mobility devices segment has been sub-segmented into wheelchair, crutch and cane, walker and rollators, and other personal mobility devices. The medical furniture segment is sub-segmented into medical bed and mattress, lift chairs, stretchers, and others. The monitoring and therapeutic devices segment is sub-segmented into blood glucose monitor, oxygen equipment, vital sign monitor, continuous passive motion (CPM), infusion pump, traction equipment, ostomy bags and accessories, cardiology devices, orthopedic braces and support, diabetic supplies, and others. The bathroom safety devices segment has been sub-segmented into commode, toilet, and others.

The global market, by end user, has been segmented into hospital/clinic, ambulatory surgical center, research centers, home healthcare, and others.

The durable medical equipment market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The durable medical equipment market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada. The increasing patient population, presence of a large number of medical device companies, and rising demand for innovative medical equipment drive the market growth in this region.

The European durable medical equipment market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 

The Asia-Pacific durable medical equipment market has been segmented into Japan, China, India, Latin Korea, Australia, and the rest of Asia-Pacific.

The durable medical equipment market in the Middle East & Africa has been segmented into the Middle East and Africa. There is an increase in the market growth in this region due to the increasing development in healthcare infrastructure and growing economy in countries such as Kuwait, Iran, Israel, and Iraq.  

Key Players

Compass Health Brand (US), GE Healthcare (US), Getinge AB (US), GF Health Products Inc. (US), Invacare Corporation (US), Medtronic Inc. (Ireland), Sunrise Medical (UK), Koninklijke Philips NV (UK), Medline Industries Inc. (US), Masimo (US), ArjoHuntleigh (UK), Hill-Rom (US), Stryker (US) and Medical Device Depot, Inc. (US) are some of the key players in the global durable medical equipment market. 

Regional Market Summary

Geographically, the market has been segmented, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is anticipated to dominate the global durable medical equipment market owing to a well-developed healthcare sector, the presence of a large number of medical device companies in this region boosts the market growth. Additionally, the presence of a large number of patient population suffering from chronic disorders and the rising demand for technologically advanced products is the key factor attributing to the growth of this region.  

Europe is expected to hold the second-largest position in the global durable medical equipment market. The increasing technological advancement in the healthcare industry, growing mergers & acquisition, and presence of a large number of healthcare organizations drives the market growth in this region. For instance, Alabama Durable Medical Equipment Association (ADMEA) is a Europe-based non-profit organization involved in providing home medical equipment in the region. Thus, such organizations drive market growth during the forecasted period.

Asia-Pacific is expected to be fastest-growing region owing to the huge patient pool suffering from chronic diseases such as diabetes, cancer, arthritis, asthma, and many more diseases. Additionally, the increasing geriatric population drives the growth of this market. According to a fact sheet published by the World Health Organization in February 2018, it was reported that in 2015, 12% of the world’s population was over 60 years and estimated that it will increase to 22% by 2050. The growing geriatric population across the world is expected to increase the burden of the patient population and ultimately drives the demand for medical equipment.

The Middle East & Africa holds the least share of the market. Majority of the market of this region is expected to be held by the Middle East region due to its well-developed healthcare sector and growing government initiatives for the development of the healthcare sector.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/durable-medical-equipment-market-2676 

Worldwide Molecular Diagnostics Market Booming Industry Size And Revenue | Future Vision Footbridge 2025 In Healthcare Sector

 Market Highlights

The Global Molecular Diagnostics Market is expected to register a CAGR of 8.57% during the forecast period, with a market value of USD 16,319.09 Million by 2025.

Molecular diagnostics is a collection of techniques used to analyze biological markers in genome and proteome. It helps to diagnose and monitor the diseases and decide which therapy should be administered to the patient based on the diagnosis. However, the rising prevalence of the infectious disease, increasing awareness regarding molecular diagnostic technique, and advancement in molecular diagnostics are the factors responsible for market growth during the forecast period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1171  

Rising prevalence of infectious diseases, advancements in molecular diagnostic techniques, and increasing prevalence of different types of cancer are likely to contribute to the growth of the market during the assessment period. For instance, as per a survey carried out by the World Health Organisation (WHO), around 9.6 million deaths caused by cancer were recorded in 2018 globally. However, stringent regulatory policies are likely to restrain the market growth during the forecast period.

Segment Analysis

The global molecular diagnostics market has been segmented into product, technique, application, and end user. By product, the market has been segregated into reagents & kits, instruments, and services & software. On the basis of technique, the market has been divided into polymerase chain reaction (PCR), isothermal amplification, hybridization, sequencing, microarray, and others. Based on application, the market has been bifurcated into infectious diseases, oncology, genetic tests, and others. By end user, the market has been categorized as hospitals & clinics, diagnostic laboratories, and others. The hospitals & clinics segment accounted for a market value of USD 4.078.09 million in 2018.

Market Players

Market Research Future (MRFR) recognizes the following companies as key players in the global Molecular Diagnostics market that include F. Hoffmann-La Roche Ltd (Switzerland), Hologic, Inc. (US), QIAGEN (Europe), Becton, Dickinson and Company (US), Abbott Laboratories (US), Cepheid (US), Siemens (Germany), CLONIT SRL (Italy), Thermo Fisher Scientific(US), Agilent Technologies(California), EKF Diagnostics (UK), Novartis (Switzerland), and Illumina (US).

Regional Analysis

The global molecular diagnostics market, based on region, has been classified as the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is estimated to dominate the global molecular diagnostics market during the forecast period. This is attributed to the increasing geriatric population, and the availability of advanced healthcare facilities in the region play a vital role in the growth of the regional market. The Europe market for molecular diagnostics is expected to be the second-largest during the forecast period. The availability of funds for research & development and rising support from the government toward the life science sector is expected to boost the growth of the market in this region.

Additionally, the companies operating in the market are mainly focusing on mergers & acquisition, which is expected to support market growth. Asia-Pacific is estimated to be the fastest-growing market due to developing economies such as China, India, and South Korea emerging as major destinations for the outsourcing of clinical trials, drug manufacturing, and pathology testing. In addition to this, improving healthcare infrastructure has increased the number of research activities in the region. Moreover, in Asia-Pacific, China accounted for a market share of 21.4% in 2018. Furthermore, the market in the Middle East & Africa is expected to witness steady growth during the review period due to the lack of awareness regarding healthcare facilities.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/molecular-diagnostics-market-1171 

World Active Pharmaceutical Ingredients Market Top Key Players Shares, Revenue, Analysis And Forecasts To 2023

 Market Highlights

The active pharmaceutical ingredient (API) market globally is expected to expand with a CAGR of 4.93 percent during the forecast period while earning revenues past the USD 215 billion mark by the year 2023. The outlook for growth in the economy is likely to perceive a sweeping rise in the API industry owing to the growing occurrence of chronic disorders such as diabetes, cardiovascular diseases, obesity and other infectious diseases which will lead to the launch of numerous innovative drugs. The rising cases of chronic diseases are also one of the foremost reasons for hospitalization with a huge number of patients with these conditions who may need re-admission in hospitals owing to an infection that can cause other chronic diseases. The expiration of patents of branded drugs has created a serious impression on drug manufacturers, as the companies can incur tremendous losses after expiration. Hence, the producers favor generic drugs over the branded ones. The generics are also expected to be the most rapidly growing type due to patent expirations of many blockbuster drugs.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1385 

Active Pharmaceutical Ingredients or API, in short, are growing in an increscent manner due to the unmatched effects of active chemicals in the drugs and the portions that work on treating the condition. The bridging of foreign manufacturers and local distributors has led to extensive progress in the market over the past few years. The launch of innovative and improved APIs in the market will boost the market’s progress to a great extent in the forthcoming period. Moreover, the constantly growing demand for biotech API has stimulated the firms to present better and new products to address the unmet requirements of the market.

The active pharmaceutical ingredient (API) market globally is expected to expand with a CAGR of 4.93 percent during the forecast period while earning revenues past the USD 215 billion mark by the year 2023. The outlook for growth in the economy is likely to perceive a sweeping rise in the API industry owing to the growing occurrence of chronic disorders such as diabetes, cardiovascular diseases, obesity and other infectious diseases which will lead to the launch of numerous innovative drugs. The rising cases of chronic diseases are also one of the foremost reasons for hospitalization with a huge number of patients with these conditions who may need re-admission in hospitals owing to an infection that can cause other chronic diseases. The expiration of patents of branded drugs has created a serious impression on drug manufacturers, as the companies can incur tremendous losses after expiration. Hence, the producers favor generic drugs over the branded ones. The generics are also expected to be the most rapidly growing type due to patent expirations of many blockbuster drugs.

However, the rapidly increasing scope for high-potency active pharmaceutical ingredients over the last decade has shifted the focus to the new biologics gold rush of recombinant proteins and monoclonal antibodies. As a result of this, the chemical API market for western contract manufacturers, on the whole, has undergone a sharp decline till 2015. Many custom manufacturing organizations (CMOs) have shifted their emphasis to rescheduling plants or manufacturing of higher-value biologics.

Segmental Analysis

The segmental analysis of the market is based on the segments of the manufacturing process, API formulation, application, type of synthesis, molecule, and region. The market segmentation by type of synthesis consists of biotech and synthetic segments. The synthetic segment in 2017 was worth USD 132,690.7 Mn. The manufacturing process based segmentation of the market comprises of contract manufacturing and captive manufacturing. The captive manufacturing segment presently has the significant market share and is expected to remain extremely lucrative throughout the assessment period. The API formulation segments the market into innovative API and generic API. The generic API segment presently held the leading market share in 2017. The segmentation based on molecule has been segmented into small molecule and large molecule. The small molecule segment is expected to maintain its top position till the end of 2023. The application based segmentation of the market has been segmented into oncology, cardiovascular disease, orthopedic disorders, neurological disorders, respiratory, urology, gastrointestinal disorders and others. The oncology segment is anticipated to develop with an incremental CAGR during the forecast period.

Regional Analysis

The market for APIs has been segmented into Europe, Americas, Asia Pacific (APAC), and the Middle East & Africa (MEA). The Americas region presently controls the significant market portion, and the trend will probably carry on in the foreseeable future. This factor is majorly related to the robust value sustained by the small molecule segment in both Canada and the U.S. Additionally the pharmaceutical industry is among one of the major and most exceptional ventures in the US nations. The pharmaceutical organizations in the USA have developed quickly in comparison with other countries. The European and Asia Pacific region are also anticipated to continue growth in the revenue pockets for the active pharmaceutical ingredients (API) market during the forecast period. Europe accounts for the second largest market for active pharmaceutical ingredients which is followed by the Asia Pacific region. While the APAC region, the market’s course is mostly directed by factors such as the amplified level of expense on equipment and infrastructure, expanding initiatives which are motivating investment in APIs from drug makers to increase the capacity to produce APIs.

Competitive Analysis

The players and key trends have created a positive tone for development. The competitors in the market are also leveraging their competitive benefits to secure their development in the market. The market progress by competitors also encompasses strong risk management strategies which are positively motivating the expansion of the market.

Bayer AG, Eli Lilly and Company, Pfizer Inc., F. Hoffmann-La Roche AG, Sanofi, Boehringer Ingelheim GmbH, Abbott Laboratories, GlaxoSmithKline Plc (GSK), Novartis AG, Merck & Co., Inc., and Teva Pharmaceutical Industries Ltd.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/active-pharmaceutical-ingredients-market-1385